# Protein toxin payloads and immunotoxins

Source: https://onco.cc/terms/protein-toxin-payloads/  
OnCo record `protein-toxin-payloads` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An antibody can deliver a protein toxin that stops a cell making proteins. These larger payloads belong to the related field of immunotoxins and need different delivery and safety studies.

## Summary

DeBouganin is a modified ribosome-inactivating protein. A primary study tested trastuzumab-deBouganin conjugates and an antibody-fragment fusion protein in cells resistant to tubulin-payload conjugates. Both chemical conjugation and fusion-protein delivery were examined. These protein toxins are different from small-molecule degraders such as GSPT1 payloads and from conventional chemotherapy payloads. The cited cellular results do not establish clinical activity after antibody-drug conjugate treatment.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: ribosome-inactivating protein payloads; deBouganin; bouganin conjugates

## Sources

- DeBouganin conjugates and fusion proteins in resistant cells (2016): https://doi.org/10.3390/molecules21121741

## Connected records

- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)
- terms: [Next-generation antibody-conjugate payloads](https://onco.cc/terms/next-generation-adc-payloads/), [Payload (ADC)](https://onco.cc/terms/payload/)

---
JSON: https://onco.cc/api/v1/entities/protein-toxin-payloads.json